This inventor holds 1 USPTO granted patent. Top assignees: Targeted Genetics Corporation, University of Pittsburgh. Active years: 1999.
Company Filing History:
1 out of 20 
1 out of 1,957 
Years Active: 1999
Title: The Innovative Contributions of David L. Sloane
Introduction
David L. Sloane is a notable inventor based in Bainbridge Island, Washington. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that focuses on lipid-comprising drug delivery complexes. His work has implications for gene therapy and other medical applications.
Latest Patents
David L. Sloane holds a patent for "Stable lipid-comprising drug delivery complexes and methods for their production." This patent describes novel stable, concentrated, biologically active, and ready-to-use lipid-comprising drug delivery complexes. The biological activity of these complexes is comparable to formulations prepared using prior art admixture methods. Upon purification, the complexes produced by Sloane's method are 50 to 500 times more concentrated than those formed by admixture. This method allows for large-scale production of lipid-comprising drug delivery systems, which are useful for gene therapy and various other applications.
Career Highlights
Throughout his career, David L. Sloane has worked with prestigious institutions, including the University of Pittsburgh and Targeted Genetics Corporation. His experience in these organizations has contributed to his expertise in drug delivery systems and biotechnology.
Collaborations
David has collaborated with notable individuals in his field, including Leaf Huang and Xiang Gao. Their combined efforts have further advanced the research and development of innovative drug delivery methods.
Conclusion
David L. Sloane's contributions to the field of drug delivery systems through his innovative patent and collaborations highlight his importance as an inventor. His work continues to influence advancements in gene therapy and related applications.